Episode Summary

Guest: Chris Tew, former medical technology executive and cancer survivor

In this episode, Chris Tew shares his journey with multiple myeloma after being diagnosed on his 69th birthday in 2021.

Key Points:

• Despite extensive standard treatments, Chris's cancer marker plateaued at 0.24 while side effects damaged his heart and threatened his vision.

• His alternative protocol: Fenbendazole (220mg) and ivermectin (36mg) five days weekly, taken with butter for better absorption.

• Within two weeks, his cancer marker became undetectable.

Chris explains how his 45 years in medical technology gave him the confidence to make an "asymmetric bet"—a calculated health decision with potentially high upside and minimal downside. While maintaining deep respect for his medical team, he shares how cancer unexpectedly became his teacher, bringing him patience, compassion, and a profound sense of gratitude that transformed his outlook on life.

_____________

This episode is brought to you by Fierce Health.

My wife and I have been microdosing Semaglutide through Fierce as part of our ​Cancer Protocol​ for the past 6 months.

Fierce Health offers:

• Personalized plans with GLP-1s, peptides, and more

• Access to real medical professionals (not bots)

• Ongoing coaching so you don’t just get meds — you get a plan and momentum

Use code PODCAST for 10% off.

_____________

This interview is part of the reason why we are building Cancer Crew, a private community for those navigating cancer—whether you’re the one diagnosed or supporting your loved one. Click to join the waitlist now.